Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome

Clinical trial NCT00043134 · UNKNOWN

Trial details

NCT number: NCT00043134
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms

Start date: 2002-05-01
Primary completion: 2008-05-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.